Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariavittoria Locci

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 29, 2018
Dextrose intravenous fluid therapy in labor reduces the length of the first stage of laborMelissa Riegel, Johanna Quist-Nelson, Gabriele Saccone, et al.
The Breast Journal|July 25, 2019
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analoguesAlessandro Conforti, Francesco Schettini, Roberta Vallone, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 6, 2024
Prenatal identification of invasive placentation using ultrasound in women with placenta previa and prior cesarean deliveryGianluigi Califano, Gabriele Saccone, Giuseppe Maria Maruotti, et al.
Scientific Reports|July 24, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving OlaparibFrancesco Schettini, Maria Valeria De Bonis, Carla Strina, et al.
American Journal of Obstetrics & Gynecology MFM|April 20, 2024
Randomized trial of screening for preterm birth in low-risk women - the preterm birth screening studyGabriele Saccone, Giuseppe Maria Maruotti, Maddalena Morlando, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial resultsSabino De Placido, Mario Giuliano, Francesco Schettini, et al.
Cancers|April 3, 2021
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Mario Giuliano, Fabiola Giudici, et al.
NPJ Breast Cancer|January 5, 2021
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancerFrancesco Schettini, Nuria Chic, Fara Brasó-Maristany, et al.
NPJ Breast Cancer|April 29, 2023
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancerFrancesco Schettini, Nuria Chic, Fara Brasó-Maristany, et al.
Cancer Treatment Reviews|January 31, 2020
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisFrancesco Schettini, Tomás Pascual, Benedetta Conte, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 29, 2018
Dextrose intravenous fluid therapy in labor reduces the length of the first stage of laborMelissa Riegel, Johanna Quist-Nelson, Gabriele Saccone, et al.
The Breast Journal|July 25, 2019
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analoguesAlessandro Conforti, Francesco Schettini, Roberta Vallone, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 6, 2024
Prenatal identification of invasive placentation using ultrasound in women with placenta previa and prior cesarean deliveryGianluigi Califano, Gabriele Saccone, Giuseppe Maria Maruotti, et al.
Scientific Reports|July 24, 2023
Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving OlaparibFrancesco Schettini, Maria Valeria De Bonis, Carla Strina, et al.
American Journal of Obstetrics & Gynecology MFM|April 20, 2024
Randomized trial of screening for preterm birth in low-risk women - the preterm birth screening studyGabriele Saccone, Giuseppe Maria Maruotti, Maddalena Morlando, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial resultsSabino De Placido, Mario Giuliano, Francesco Schettini, et al.
Cancers|April 3, 2021
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Mario Giuliano, Fabiola Giudici, et al.
NPJ Breast Cancer|January 5, 2021
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancerFrancesco Schettini, Nuria Chic, Fara Brasó-Maristany, et al.
NPJ Breast Cancer|April 29, 2023
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancerFrancesco Schettini, Nuria Chic, Fara Brasó-Maristany, et al.
Cancer Treatment Reviews|January 31, 2020
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisFrancesco Schettini, Tomás Pascual, Benedetta Conte, et al.
Pageof 6